Ledger.Open graph →
SEC Form D · filed April 13, 2020

Stealth BioTherapeutics Corp

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GRAND CAYMAN, Cayman Islands
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Lu Huang · Newton, MADirectorFrancis Chen · Newton, MADirectorIrene Mccarthy · Newton, MAExec · DirectorEdward Owens · Newton, MADirectorKevin Mclaughlin · Newton, MADirectorGerald Chan · Newton, MADirectorLou Lange · Newton, MADirectorDavid Eaton · Vancouver, British Columbia, CanadaDirectorQueenie Kuang · Vancouver, British Columbia, CanadaDirectorKirk R. Ouimet · Meridian, IDDirectorHerrick Lau · Vancouver, British Columbia, CanadaDirectorGarrett B. Gee · Meridian, IDDirectorDonald Hatcher · Southlake, TXDirectorRichard J. Leifels · Stamford, CTExec · DirectorMichael G. O'Hara · New York, NYExec · DirectorThomas D. Wagner · New York, NYDirectorAra D. Cohen · New York, NYDirectorJonathan Herzog · Encino, CADirectorJohn Pingel · San Francisco, CADirectorMichael Gorriaran · Washington, Washington, D.C.DirectorAdam Treiser · Washington, Washington, D.C.Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗